[HTML][HTML] High phosphate-induced calcification of vascular smooth muscle cells is associated with the TLR4/NF-κb signaling pathway

D Zhang, X Bi, Y Liu, Y Huang, J Xiong, X Xu… - Kidney and Blood …, 2018 - karger.com
Background/Aims: Hyperphosphatemia is one of the most notable features of chronic kidney
disease (CKD). Numerous epidemiological and clinical studies have found that high serum …

Update on current and emerging treatment paradigms for hyperphosphatemia in chronic kidney disease

D Salera, A Bellasi, L Del Vecchio… - Expert Opinion on …, 2025 - Taylor & Francis
Introduction Hyperphosphatemia in advanced CKD often accompanies high PTH and
FGF23 levels, impaired bone mineralization, ectopic calcifications, and increased …

Genome-wide identification of lncRNAs and mRNAs differentially expressed in human vascular smooth muscle cells stimulated by high phosphorus

S Bao, Y Guo, Z Diao, W Guo, W Liu - Renal Failure, 2020 - Taylor & Francis
Background Cardiovascular events are the primary cause of death for chronic kidney
disease patients, which occurred via vascular calcification evolving pathogenically. Although …

Recirculating peritoneal dialysis system using urease-fixed silk fibroin membrane filter with spherical carbonaceous adsorbent

MT Sultan, BM Moon, JW Yang, OJ Lee, SH Kim… - Materials Science and …, 2019 - Elsevier
The chronic kidney disease (CKD) patients are undergoing continuous ambulatory
peritoneal dialysis (CAPD). However, there are some constraints, the frequent exchange of …

Characteristics, Risk Factors, and Outcomes in Acute Kidney Injury Patients: A Retrospective Cross‐Sectional Study, Palestine

A Damin Abukhalil, H Alyazouri… - The Scientific World …, 2024 - Wiley Online Library
Background. Acute kidney injury (AKI) is a major medical problem affecting patients' quality
of life and healthcare costs. Objectives. This study evaluated the severity, risk factors, and …

[HTML][HTML] Long-term effectiveness of cinacalcet in non-dialysis patients with chronic kidney disease and secondary hyperparathyroidism

A Pérez-Ricart, M Galicia-Basart… - Kidney research and …, 2019 - ncbi.nlm.nih.gov
Background Secondary hyperparathyroidism (SHPT) is a common complication of chronic
kidney disease (CKD). Cinacalcet use is controversial in non-dialysis patients. Methods This …

[HTML][HTML] Serum Phosphorus Management with Sucroferric Oxyhydroxide as a First-Line Phosphate Binder within the First Year of Hemodialysis

JA Medaura, M Zhou, LH Ficociello, MS Anger… - American Journal of …, 2024 - karger.com
Abstract Introduction: Sucroferric oxyhydroxide (SO), a non-calcium, chewable, iron-based
phosphate binder (PB), effectively lowers serum phosphorus (sP) concentrations while …

An equation based on fuzzy mathematics to assess the timing of haemodialysis initiation

Y Liu, D Wang, X Chen, X Sun, W Song, H Jiang… - Scientific Reports, 2019 - nature.com
In order to develop an equation that integrates multiple clinical factors including signs and
symptoms associated with uraemia to assess the initiation of dialysis, we conducted a …

Hemodiyaliz tedavisi alan bireylerde egzersiz davranışı ve yaşam kalitesi arasındaki ilişki

A Kaya - 2022 - search.proquest.com
TC BALIKESİR ÜNİVERSİTESİ SAĞLIK BİLİMLERİ ENSTİTÜSÜ Page 1 1 TC BALIKESİR
ÜNİVERSİTESİ SAĞLIK BİLİMLERİ ENSTİTÜSÜ TR, Balıkesir University, Institute of Health …

[PDF][PDF] Predialysis vascular access creation: to whom and when

R Escoli, I Luz, P Santos, AV Lobos - Port J Nephrol Hypert, 2017 - academia.edu
∎ ABSTRACT Aims: The optimal timing of predialysis vascular access surgery remains
uncertain. This study goal was to evaluate the influence of kidney function and clinical …